CD86 and melanoma: Uveal melanoma patients also had higher fractions of CD16+ intermediate and non-classical monocytes which are regarded as inflammatory monocytes.15 The CD16+ monocytes in melanoma patients showed signs of activation as they expressed increased levels of CD86, HLA-ABC and PD-L1, compared with healthy controls (Figure 1b,d).